The goal of the NCI is to eliminate the suffering and death due to cancer. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are NCI's engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer.
The SBIR & STTR Programs are one of the largest sources of early-stage technology
financing in the United States. We welcome entrepreneurs and small business leaders
to this website to explore grant and contract funding opportunities and a new spirit
of collaboration with the NCI.
NIH requires grantees to acknowledge federal funding in stories released for public dissemination, including news releases, peer-reviewed publications, and presentations. We are asking all awardees to begin mentioning their NIH grant or contract number specifically in all external communications of this nature. Click here for additional information.
The NCI Clinical Assay Development Program (CADP) is requesting project applications from investigators seeking clinical assay validation resources that are designed to assist with the development of assays that may predict therapy response or prognostic behavior of a diagnosed cancer, primarily for use in clinical trials. Approved projects for the NCI CADP will be provided access to the Institute's assay development and validation resources, including project management support. For more information on the CADP or to submit an application, please visit: http://cadp.cancer.gov/. Please note that this call for applications is not a solicitation for biomarker discovery and is not a grants program.
Upcoming Receipt Date: February 15, 2013
The National Cancer Institute (NCI) announced a new Program Announcement, aimed at accelerating the development and commercialization of consumer health information technology products that translate the behavioral and communication science evidence base for the prevention and control of cancer and other chronic diseases. The NCI and the National Library of Medicine (a co-funding partner) are interested in supporting the development and dissemination of evidence-based health information technology (health IT) products that have the potential to prevent or reduce the risk of cancer, facilitate patient-provider communication and/or improve disease outcomes in consumer and clinical settings. Please click here for more information.
Upcoming Receipt Date: April 5, 2013
The NCI SBIR Development Center is interested in learning more about how SBIR & STTR funding is helping your company to achieve its cancer research goals and business objectives. Please click here to fill out a 'Share Your Story' form, and let us know about any developments with your NCI SBIR- or STTR-funded projects. Learn more about how other successful NCI SBIR & STTR companies are using their funding awards to advance cancer research.
NCI SBIR Development Center Director Michael Weingarten led a webinar in October 2012 for state Biotechnology Industry Organization (BIO) members. The webinar was held in collaboration with the Council of State Bioscience Associations (CSBA), and focused on the SBIR & STTR Programs, upcoming legislative changes that will expand the program, and funding opportunities aimed at progressing cancer research. Please click here to view the presentation from this webinar.
In an article published in Nature Biotechnology, SBIR & STTR Development Center staff discuss the application process and provide tips for applying for funding through the SBIR & STTR Programs.
Each year, the NCI prepares a budget proposal describing NCI-supported scientific advancements and how the nation works together to control cancer and its effects. Please click here to view the 2013 plan.
NCI intends to commit $10M for up to ten new Phase IIB Bridge awards in FY2013. Click here to learn more.
Apply by: March 6, 2013
For ongoing updates on NIH implementation of key changes from the SBIR/STTR Reauthorization Act of 2011, please continue to check the NIH implementation plan website.
To review a summary of the key changes, please visit http://www.sba.gov/about-sba-info/174308
- Innovative Health IT for Broad Adoption by Healthcare Systems and Consumers
- Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology
View a complete list of funding opportunities.
NCI Director Harold Varmus launched a website as part of the Provocative Questions Initiative to identify the most important questions in the cancer research community.